Barclays PLC Guardant Health, Inc. Call Options Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$16.07 - $31.84 $731,185 - $1.45 Million	45,500 New	45,500 $1.31 Million
Q1 2021 May 13, 2021	SELL	$127.04 - $179.1 $10.5 Million - $14.8 Million	-82,500 Reduced 73.33%	30,000 $4.58 Million
Q2 2019 Aug 14, 2019	SELL	$63.94 - $91.11 $159,850 - $227,775	-2,500 Reduced 2.17%	112,500 $9.71 Million
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $3.94 Million - $11.3 Million	115,000 New	115,000 $8.82 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.